Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
October 21, 2002
MILWAUKEE--Chr. Hansen announced in late August astrategic alliance with Denmark-based Novozymes that will combine Novozymes'research and development of enzymes with Chr. Hansen's ingredient applicationsto the dairy industry. The complementary competencies and technologies forenzymes targeted to the dairy industry will be the basis for the alliance,according to a press release from Chr. Hansen (www.chr-hansen.com).The alliance is focused on the future and market expansion, but the agreementexcludes coagulant activities.
"The strong research and development and productioncapabilities of Novozymes combined with our strength in applications, technicalservice, sales experience and overall market knowledge, will result in a truepartnership that will expand our services and products," said David R.Carpenter, senior vice president at Chr. Hansen. "The benefit to the dairyindustry will be in the increased value of their products and improvement inproduction efficiency."
Steen Riisgaard, chief executive officer at Novozymes, added,"In our new strategy, Novozymes has focused on a handful of new marketexpanding areas within enzymes. One of these areas is prepared food andtherefore also enzymes for the dairy industry. We have good experiences withalliances and see attractive business opportunities in cooperating with Chr.Hansen on this area."
You May Also Like
9 of 10 Amazon galantamine memory supplements failed to meet label claimFeb 23, 2024
ABC reports herbal sales fell 1.9% in 2022Feb 22, 2024
Here's why creatine sales are surging this past yearFeb 21, 2024
DSHEA's 25th anniversary: Industry vets, critics respondFeb 21, 2024